IDH1 and glioblastoma: This discussion raised the additional challenge that in some tumor types (eg, IDH‐mutant glioblastoma or WNT‐subgroup medulloblastoma in a child), stressing the WHO grade in the diagnosis may be more confusing than helpful, and that such situations may require a comment stating that the prognosis is better in such a molecular subtype than suggested by the grade.